Table 3.
Nanotherapies targeting non-cellular components in HNSCC.
| Nanoparticles | Cargoes | Target | Response | Application | Refs | 
|---|---|---|---|---|---|
| CECMa | Cisplatin and metformin | Hypoxia | Targeting the hypoxic tumor region, and co-delivers cisplatin and metformin | Co-delivers cisplatin and metformin | (70) | 
| TiO2 | Ru complex and HIF-1α siRNA | Hypoxia | Silencc of HIF-1α | Combined with PDT | (71) | 
| Nanohydrogel | nano DOX and nano ICG | ECM | Sustained release nano DOX and nano ICG with the presence of MMPs | Combined with 808nm NIR irradiation | (72) | 
| Extracellular vesicle | MMP13 | ECM | Inducing EMT of the recipient normoxic cell | Knocking down MMP13 in EVs | (73) |